Key criteria for assessing quality, compliance, and reliability in compounding partners.
For practices adding peptide programs, IV wellness, or other advanced modalities, the compounding pharmacy you partner with is one of the most consequential decisions you'll make. The wrong partner creates compliance risk, quality issues, and patient safety concerns. Here's what to evaluate — and why it matters.
The first and most critical criterion is regulatory standing. Your compounding partner should hold active state pharmacy licenses in every state where they operate and ship. For sterile compounding — which includes injectable peptides and IV formulations — the pharmacy must comply with USP chapters 795, 797, and 800 as applicable.
503A pharmacies compound pursuant to patient-specific prescriptions. 503B outsourcing facilities compound in larger batches and are subject to cGMP requirements. Both pathways are legitimate — but they serve different purposes, and your program design should align with the appropriate pharmacy category.
Ask about identity testing, potency testing, sterility testing, and endotoxin testing. A reputable compounding pharmacy tests every batch — not just some batches. They should be able to provide certificates of analysis upon request and maintain records that support full traceability from raw material to finished product.
Third-party testing adds an independent layer of verification. Pharmacies that invest in outside laboratory analysis demonstrate a commitment to quality that goes beyond minimum regulatory requirements.
Active Pharmaceutical Ingredients (APIs) should be sourced from FDA-registered suppliers with documentation of Current Good Manufacturing Practice (cGMP) compliance. Your pharmacy should maintain records of API sourcing, including certificates of origin and analysis, and should be transparent about their supply chain.
In the peptide space specifically, sourcing is critical. Low-quality or misidentified peptides can create both clinical and legal risk. A pharmacy that can't clearly articulate their API sourcing process is a pharmacy that shouldn't be handling your patients' prescriptions.
Beyond quality, your pharmacy needs to be operationally reliable. That means consistent turnaround times, adequate inventory management, reliable shipping with temperature control where required, and responsive customer service. A pharmacy that regularly backorders critical medications or ships without proper temperature management creates operational disruptions that affect patient care and practice revenue.
Rivital has spent years vetting compounding pharmacy partners against these exact criteria. We evaluate regulatory standing, quality systems, API sourcing, testing protocols, and operational reliability before recommending any pharmacy to our network practices. This vetting process is ongoing — because the standards that matter today are the ones you verify tomorrow.
For practices joining the Rivital network, we provide access to pre-vetted pharmacy partners along with the compliance frameworks and documentation standards that make these partnerships work. You don't have to learn this the hard way — we already have.